Last reviewed · How we verify
OraPlus
At a glance
| Generic name | OraPlus |
|---|---|
| Sponsor | Forbes Porter, M.D. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Effects of Intragastric Quinine, Alone or Combined With L-leucine, on Postprandial Glycaemic Control (NA)
- Effects of Intragastric Quinine, Alone or Combined With L-isoleucine, on Postprandial Glycaemic Control (NA)
- Simvastatin Therapy in Smith-Lemli-Opitz Syndrome (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- OraPlus CI brief — competitive landscape report
- OraPlus updates RSS · CI watch RSS
- Forbes Porter, M.D. portfolio CI